Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Jelena Savović"'
Autor:
Sean Harrison, Hunaid A. Vohra, Gianni D Angelini, Massimo Caputo, Paul Rival, Tom A Rayner, Jelena Savović, Dominic E. Mahoney
Publikováno v:
Eur J Cardiothorac Surg
Rayner, T A, Harrison, S, Rival, P M, Mahoney, D E, Caputo, M, Angelini, G, Savović, J & Vohra, H 2019, ' Minimally Invasive versus Conventional Surgery of the Ascending Aorta and Root : A Systematic Review and Meta-Analysis ', European Journal of Cardio-Thoracic Surgery . https://doi.org/10.1093/ejcts/ezz177
Rayner, T A, Harrison, S, Rival, P M, Mahoney, D E, Caputo, M, Angelini, G, Savović, J & Vohra, H 2019, ' Minimally Invasive versus Conventional Surgery of the Ascending Aorta and Root : A Systematic Review and Meta-Analysis ', European Journal of Cardio-Thoracic Surgery . https://doi.org/10.1093/ejcts/ezz177
Summary Limited uptake of minimally invasive surgery (MIS) of the aorta hinders assessment of its efficacy compared to median sternotomy (MS). The objective of this systematic review is to compare operative and perioperative outcomes for MIS versus M
Publikováno v:
Systematic Reviews, Vol 6, Iss 1, Pp 1-9 (2017)
Europe PubMed Central
Whiting, P, Wolff, R F, Mallett, S, Simera, I & Savović, J 2017, ' A proposed framework for developing quality assessment tools ', Systematic Reviews, vol. 6, 204 . https://doi.org/10.1186/s13643-017-0604-6
Systematic Reviews
Europe PubMed Central
Whiting, P, Wolff, R F, Mallett, S, Simera, I & Savović, J 2017, ' A proposed framework for developing quality assessment tools ', Systematic Reviews, vol. 6, 204 . https://doi.org/10.1186/s13643-017-0604-6
Systematic Reviews
Background Assessment of the quality of included studies is an essential component of any systematic review. A formal quality assessment is facilitated by using a structured tool. There are currently no guidelines available for researchers wanting to
Publikováno v:
Savović, J, Akl, E A & Hróbjartsson, A 2018, ' Financial conflicts of interest in clinical research ', Intensive Care Medicine, vol. 44, no. 10, pp. 1767–1769 . https://doi.org/10.1007/s00134-018-5333-3
Savović, J, Akl, E A & Hróbjartsson, A 2018, ' Financial conflicts of interest in clinical research ', Intensive Care Medicine, vol. 44, no. 10, pp. 1767-1769 . https://doi.org/10.1007/s00134-018-5333-3
Savović, J, Akl, E A & Hróbjartsson, A 2018, ' Financial conflicts of interest in clinical research ', Intensive Care Medicine, vol. 44, no. 10, pp. 1767-1769 . https://doi.org/10.1007/s00134-018-5333-3
[no abstract]
Autor:
Natalie S Blencowe, Miguel A. Hernán, Lesley A. Stewart, Ian Shrier, Hung-Yuan Cheng, Kate Tilling, Tianjing Li, Ian R. White, Barnaby C Reeves, Sandra Eldridge, Roy G Elbers, Sally Hopewell, Jonathan A C Sterne, Jonathan Emberson, Isabelle Boutron, Jelena Savović, Alexandra McAleenan, Julian P T Higgins, Penny Whiting, Peter Jüni, Daniela R Junqueira, Sasha Shepperd, Matthew J. Page, Toby J Lasserson, Christopher J Cates, Mark Corbett, Jamie J Kirkham, Asbjørn Hróbjartsson
Publikováno v:
Sterne, J A C, Savovic, J, Page, M J, Elbers, R G, Blencowe, N S, Boutron, I, Cates, C J, Cheng, H-Y, Corbett, M S, Eldridge, S M, Emberson, J R, Hernán, M A, Hopewell, S, Hróbjartsson, A, Junqueira, D R, Jüni, P, Kirkham, J, Lasserson, T, Li, T, McAleenan, A, Reeves, B C, Shepperd, S, Shrier, I, Stewart, L A, Tilling, K, White, I R, Whiting, P F & Higgins, J P T 2019, ' RoB 2: a revised tool for assessing risk of bias in randomised trials ', The BMJ, vol. 366, l4898 . https://doi.org/10.1136/bmj.l4898
Sterne, J A C, Savović, J, Page, M J, Elbers, R G, Blencowe, N S, Boutron, I, Cates, C J, Cheng, H Y, Corbett, M S, Eldridge, S M, Emberson, J R, Hernán, M A, Hopewell, S, Hróbjartsson, A, Junqueira, D R, Jüni, P, Kirkham, J J, Lasserson, T, Li, T, McAleenan, A, Reeves, B C, Shepperd, S, Shrier, I, Stewart, L A, Tilling, K, White, I R, Whiting, P F & Higgins, J P T 2019, ' RoB 2 : A revised tool for assessing risk of bias in randomised trials ', The BMJ, vol. 366, l4898 . https://doi.org/10.1136/bmj.l4898
Sterne, J A C, Savović, J, Page, M J, Elbers, R G, Blencowe, N S, Boutron, I, Cates, C J, Cheng, H-Y, Corbett, M S, Eldridge, S M, Emberson, J R, Hernán, M A, Hopewell, S, Hróbjartsson, A, Junqueira, D R, Juni, P, Kirkham, J J, Lasserson, T, Li, T, McAleenan, A, Reeves, B C, Shepperd, S, Shrier, I, Stewart, L A, Tilling, K, White, I R, Whiting, P F & Higgins, J P T 2019, ' RoB 2 : a revised tool for assessing risk of bias in randomised trials ', BMJ, vol. 366, l4898 . https://doi.org/10.1136/bmj.l4898
Sterne, J A C, Savović, J, Page, M J, Elbers, R G, Blencowe, N S, Boutron, I, Cates, C J, Cheng, H Y, Corbett, M S, Eldridge, S M, Emberson, J R, Hernán, M A, Hopewell, S, Hróbjartsson, A, Junqueira, D R, Jüni, P, Kirkham, J J, Lasserson, T, Li, T, McAleenan, A, Reeves, B C, Shepperd, S, Shrier, I, Stewart, L A, Tilling, K, White, I R, Whiting, P F & Higgins, J P T 2019, ' RoB 2 : A revised tool for assessing risk of bias in randomised trials ', The BMJ, vol. 366, l4898 . https://doi.org/10.1136/bmj.l4898
Sterne, J A C, Savović, J, Page, M J, Elbers, R G, Blencowe, N S, Boutron, I, Cates, C J, Cheng, H-Y, Corbett, M S, Eldridge, S M, Emberson, J R, Hernán, M A, Hopewell, S, Hróbjartsson, A, Junqueira, D R, Juni, P, Kirkham, J J, Lasserson, T, Li, T, McAleenan, A, Reeves, B C, Shepperd, S, Shrier, I, Stewart, L A, Tilling, K, White, I R, Whiting, P F & Higgins, J P T 2019, ' RoB 2 : a revised tool for assessing risk of bias in randomised trials ', BMJ, vol. 366, l4898 . https://doi.org/10.1136/bmj.l4898
Assessment of risk of bias is regarded as an essential component of a systematic review on the effects of an intervention. The most commonly used tool for randomised trials is the Cochrane risk-of-bias tool. We updated the tool to respond to developm
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e4d2aa6206811096a0c47db070fa50b1
https://eprints.whiterose.ac.uk/150579/1/bmj.l4898.full.pdf
https://eprints.whiterose.ac.uk/150579/1/bmj.l4898.full.pdf
Autor:
Chris Salisbury, Wei Fang, Annya Stephens-Boal, Reecha Sofat, Philippa Davies, Diane Eaton, Zhenru Wang, Howard Thom, Aroon D. Hingorani, Peter Bryden, Alison Richards, William Hollingworth, José A López-López, Jelena Savović, Nicky J Welton, Jonathan A C Sterne, Sofia Dias, Deborah M Caldwell, Pritesh N Bodalia, Julian P T Higgins, G N Okoli
Publikováno v:
MDM Policy & Practice
Thom, H, Hollingworth, W, Sofat, R, Wang, Z, Fang, W, Bodalia, P N, Bryden, P, Davies, P, Caldwell, D, Dias, S, Eaton, D, Higgins, J, Hingorani, A D, Lopez-Lopez, J, Okoli, G, Richards, A, Salisbury, C, Savović, J, Stephens-Boal, A, Sterne, J & Welton, N 2019, ' Directly Acting Oral Anticoagulants for the Prevention of Stroke in Atrial Fibrillation in England and Wales : Cost-Effectiveness Model and Value of Information Analysis ', MDM Policy & Practice, vol. 4, no. 2 . https://doi.org/10.1177/2381468319866828
MDM Policy & Practice, Vol 4 (2019)
Thom, H, Hollingworth, W, Sofat, R, Wang, Z, Fang, W, Bodalia, P N, Bryden, P, Davies, P, Caldwell, D, Dias, S, Eaton, D, Higgins, J, Hingorani, A D, Lopez-Lopez, J, Okoli, G, Richards, A, Salisbury, C, Savović, J, Stephens-Boal, A, Sterne, J & Welton, N 2019, ' Directly Acting Oral Anticoagulants for the Prevention of Stroke in Atrial Fibrillation in England and Wales : Cost-Effectiveness Model and Value of Information Analysis ', MDM Policy & Practice, vol. 4, no. 2 . https://doi.org/10.1177/2381468319866828
MDM Policy & Practice, Vol 4 (2019)
Objectives. Determine the optimal, licensed, first-line anticoagulant for prevention of ischemic stroke in patients with non-valvular atrial fibrillation (AF) in England and Wales from the UK National Health Service (NHS) perspective and estimate val
Autor:
Aroon D. Hingorani, William Hollingworth, Chris Salisbury, Howard Thom, Annya Stephens-Boal, Sofia Dias, Jelena Savović, Reecha Sofat, Philippa Davies, Jonathan A C Sterne, José A López-López, Diane Eaton, Nicky J Welton, Pritesh N Bodalia, Julian P T Higgins, Peter Bryden, G N Okoli, Deborah M Caldwell
Publikováno v:
López-López, J A, Sterne, J A C, Thom, H H Z, Higgins, J P T, Hingorani, A D, Okoli, G N, Davies, P A, Bodalia, P N, Bryden, P A, Welton, N J, Hollingworth, W, Caldwell, D M, Savović, J, Dias, S, Salisbury, C, Eaton, D, Stephens-Boal, A & Sofat, R 2017, ' Oral anticoagulants for prevention of stroke in atrial fibrillation : systematic review, network meta-analysis, and cost effectiveness analysis ', BMJ, vol. 359, j5058 . https://doi.org/10.1136/bmj.j5058
Objective To compare the efficacy, safety, and cost effectiveness of direct acting oral anticoagulants (DOACs) for patients with atrial fibrillation. Design Systematic review, network meta-analysis, and cost effectiveness analysis. Data sources Medli
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e89f4f6471e04cb68f130708cd201665
https://research-information.bris.ac.uk/en/publications/8c179c5b-3adf-42f3-b6e8-8c7084a4198c
https://research-information.bris.ac.uk/en/publications/8c179c5b-3adf-42f3-b6e8-8c7084a4198c
Autor:
Laurie A. Tomlinson, Penny Whiting, Jeremy Horwood, Tracey Stone, Fergus Caskey, Andrew Morden, Charles R.V. Tomson, Thomas Blakeman, Alison Richards, Jelena Savović
Publikováno v:
Whiting, P, Morden, A, Tomlinson, L A, Caskey, F, Blakeman, T, Tomson, C, Stone, T, Richards, A, Savovic, J & Horwood, J 2017, ' What are the risks and benefits of temporarily discontinuing medications to prevent acute kidney injury? A systematic review and meta-Analysis ', BMJ Open, vol. 7, no. 4, e012674 . https://doi.org/10.1136/bmjopen-2016-012674
Whiting, P, Savović, J, Morden, A, Caskey, F, Blakeman, T, Tomson, C, Stone, T, Richards, A, Horwood, J & Tomlinson, L 2017, ' What are the risks and benefits of temporarily discontinuing medications to prevent acute kidney injury? A systematic review and meta-analysis ', BMJ Open, vol. 7, no. 4, e012674 . https://doi.org/10.1136/bmjopen-2016-012674
BMJ Open
Whiting, P, Savović, J, Morden, A, Caskey, F, Blakeman, T, Tomson, C, Stone, T, Richards, A, Horwood, J & Tomlinson, L 2017, ' What are the risks and benefits of temporarily discontinuing medications to prevent acute kidney injury? A systematic review and meta-analysis ', BMJ Open, vol. 7, no. 4, e012674 . https://doi.org/10.1136/bmjopen-2016-012674
BMJ Open
Objectives To summarise evidence on temporary discontinuation of medications to prevent acute kidney injury (AKI). Design Systematic review and meta-analysis of randomised and non-randomised studies. Participants Adults taking diuretics, ACE inhibito
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dd657079745bde06cf264775c2bf77cb
Autor:
Chris Salisbury, Philippa Davies, G N Okoli, Sofia Dias, Jonathan A C Sterne, Nicky J Welton, Pritesh N Bodalia, Julian P T Higgins, Jelena Savović, José A López-López, Diane Eaton, Annya Stephens-Boal, Reecha Sofat, Howard Thom, William Hollingworth, Peter Bryden, Deborah M Caldwell, Aroon D. Hingorani
Publikováno v:
ResearcherID
Health Technology Assessment, Vol 21, Iss 9 (2017)
Sterne, J A, Bodalia, P N, Bryden, P A, Davies, P A, López-López, J A, Okoli, G N, Thom, H H, Caldwell, D M, Dias, S, Eaton, D, Higgins, J P, Hollingworth, W, Salisbury, C, Savović, J, Sofat, R, Stephens-Boal, A, Welton, N J & Hingorani, A D 2017, ' Oral anticoagulants for primary prevention, treatment and secondary prevention of venous thromboembolic disease, and for prevention of stroke in atrial fibrillation : systematic review, network meta-analysis and cost-effectiveness analysis ', Health Technology Assessment, vol. 21, no. 9, pp. 1-438 . https://doi.org/10.3310/hta21090
Health Technology Assessment, Vol 21, Iss 9 (2017)
Sterne, J A, Bodalia, P N, Bryden, P A, Davies, P A, López-López, J A, Okoli, G N, Thom, H H, Caldwell, D M, Dias, S, Eaton, D, Higgins, J P, Hollingworth, W, Salisbury, C, Savović, J, Sofat, R, Stephens-Boal, A, Welton, N J & Hingorani, A D 2017, ' Oral anticoagulants for primary prevention, treatment and secondary prevention of venous thromboembolic disease, and for prevention of stroke in atrial fibrillation : systematic review, network meta-analysis and cost-effectiveness analysis ', Health Technology Assessment, vol. 21, no. 9, pp. 1-438 . https://doi.org/10.3310/hta21090
BackgroundWarfarin is effective for stroke prevention in atrial fibrillation (AF), but anticoagulation is underused in clinical care. The risk of venous thromboembolic disease during hospitalisation can be reduced by low-molecular-weight heparin (LMW
Autor:
Penny Whiting, Jelena Savović
Publikováno v:
Journal of Clinical Epidemiology. 76:239